We are live on ! Find out more
HQY icon

HealthEquity

366 hedge funds and large institutions have $7.07B invested in HealthEquity in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 122 increasing their positions, 138 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $10.3M

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

24% more capital invested

Capital invested by funds: $5.71B → $7.07B (+$1.36B)

4% more funds holding

Funds holding: 352366 (+14)

0.19% more ownership

Funds ownership: 100.36%100.55% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

12% less repeat investments, than reductions

Existing positions increased: 122 | Existing positions reduced: 138

Holders
366
Holders Change
+14
Holders Change %
+3.98%
% of All Funds
5.27%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
54
Increased
122
Reduced
138
Closed
36
Calls
$16.2M
Puts
$10.3M
Net Calls
+$5.88M
Net Calls Change
+$1.77M
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$27M -$1.7M -21,768 -6%
Fuller & Thaler Asset Management
52
Fuller & Thaler Asset Management
California
$25.9M +$7.04M +90,168 +40%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$22.2M +$102K +1,303 +0.5%
TCM
54
TimesSquare Capital Management
New York
$21.2M -$3.5M -44,849 -15%
SCA
55
Summit Creek Advisors
Minnesota
$20.9M +$120K +1,541 +0.6%
DDC
56
DF Dent & Co
Maryland
$20.6M -$49.1K -629 -0.2%
Man Group
57
Man Group
United Kingdom
$20.1M -$13.5M -172,439 -41%
GT
58
Glenmede Trust
Pennsylvania
$19.4M +$1.17M +15,037 +7%
Ameriprise
59
Ameriprise
Minnesota
$18.2M -$462K -5,922 -3%
EAM
60
Eagle Asset Management
Florida
$17.3M -$705K -9,023 -4%
CI
61
Cambiar Investors
Colorado
$15.6M -$656K -8,396 -4%
Barclays
62
Barclays
United Kingdom
$15.4M -$255K -3,270 -2%
GLA
63
Great Lakes Advisors
Illinois
$15.2M -$88.4K -1,132 -0.6%
AllianceBernstein
64
AllianceBernstein
Tennessee
$15.1M -$23.8K -305 -0.2%
AQR Capital Management
65
AQR Capital Management
Connecticut
$14.4M +$10.9M +139,786 +378%
Swiss National Bank
66
Swiss National Bank
Switzerland
$13.8M +$46.8K +600 +0.4%
AIG
67
American International Group
New York
$12.6M -$152K -1,948 -1%
SI
68
Scout Investments
Missouri
$12.3M -$748K -9,577 -6%
Prudential Financial
69
Prudential Financial
New Jersey
$12M -$33.3M -425,916 -74%
California Public Employees Retirement System
70
California Public Employees Retirement System
California
$12M +$97.2K +1,245 +0.9%
Point72 Asset Management
71
Point72 Asset Management
Connecticut
$12M -$25.8M -330,624 -69%
Natixis Advisors
72
Natixis Advisors
Massachusetts
$11.5M +$9.64M +123,402 +717%
MFWM
73
Motley Fool Wealth Management
Virginia
$11.2M -$140K -1,791 -1%
CS
74
Credit Suisse
Switzerland
$11M +$14.4K +184 +0.1%
Legal & General Group
75
Legal & General Group
United Kingdom
$11M +$147K +1,877 +1%

HQY Hedge Fund Activity: Q1 2024 in Review

366 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q1 2024, worth a combined $7.07B — up 24% from $5.71B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new HQY positions and 36 closed out — a net gain of 18 holders — while 122 added to existing stakes and 138 trimmed.

The largest buyer was Invesco, adding an estimated $64.8M. The largest seller was Morgan Stanley, cutting an estimated $73.8M.

  • 366 institutional investors held HealthEquity (HQY) as of Q1 2024, up from 352 in Q4 2023.
  • Funds reported $7.07B of HealthEquity stock for Q1 2024, up 24% quarter-over-quarter.
  • 54 funds opened new HealthEquity positions in Q1 2024 and 36 closed out, a net change of +18 holders.
  • The largest HealthEquity buyer in Q1 2024 was Invesco, an estimated $64.8M added.
  • The largest HealthEquity seller in Q1 2024 was Morgan Stanley, an estimated $73.8M sold.

Based on aggregated 13F filings for Q1 2024.